Refsal K R, Nachreiner R F, Stein B E, Currigan C E, Zendel A N, Thacker E L
Animal Health Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, East Lansing 48824-1316.
J Am Vet Med Assoc. 1991 Dec 1;199(11):1594-601.
Administration of triiodothyronine (liothyronine, 15 micrograms, q 8 h, for 6 treatments) caused marked decrease in serum concentration of thyroxine (T4) and estimates of free T4 (fT4) concentration in clinically normal cats. A prospective clinical study was done to evaluate the use of this suppression test for diagnosis of hyperthyroidism in cats with clinical signs suggestive of the disease, but lacking high serum concentration of iodothyronines. Twenty-three cats were confirmed as hyperthyroid on the basis of histologic changes in the thyroid gland or clinical improvement in response to administration of methimazole. Mean +/- SD serum concentration of T4 (34.3 +/- 12.7 to 31.3 +/- 11.5 nmol/L) and estimate of fT4 concentration (26.6 +/- 6.4 to 25.6 +/- 6.9 pmol/L) did not change after administration of liothyronine to these cats. Twenty-three cats were classified as nonhyperthyroid by histologic confirmation of other disease, abnormal results of other diagnostic tests that strongly supported primary disease other than hyperthyroidism, or spontaneous remission of weight loss without treatment. Mean +/- SD serum concentration of T4 (27.9 +/- 10.3 to 11.7 +/- 6.4 nmol/L) and estimate of fT4 concentration (21.7 +/- 5.4 to 10.4 +/- 4.4 pmol/L) decreased significantly (P less than 0.001) in response to administration of liothyronine. Discriminant analysis was used to identify variables from iodothyronine assays (eg, absolute concentration of T4 or absolute estimate of fT4 concentration, or changes of T4 or fT4 concentration) that provided the best diagnostic sensitivity and specificity.(ABSTRACT TRUNCATED AT 250 WORDS)
给予三碘甲状腺原氨酸(碘塞罗宁,15微克,每8小时一次,共6次治疗)可使临床正常猫的血清甲状腺素(T4)浓度及游离T4(fT4)浓度估算值显著降低。进行了一项前瞻性临床研究,以评估该抑制试验在诊断有甲亢临床症状但血清碘甲状腺原氨酸浓度不高的猫的甲状腺功能亢进症中的应用。23只猫根据甲状腺组织学变化或服用甲巯咪唑后的临床改善情况被确诊为甲状腺功能亢进。对这些猫给予碘塞罗宁后,T4的平均±标准差血清浓度(34.3±12.7至31.3±11.5纳摩尔/升)及fT4浓度估算值(26.6±6.4至25.6±6.9皮摩尔/升)未发生变化。23只猫通过其他疾病的组织学确诊、强烈支持非甲亢原发性疾病的其他诊断试验异常结果或未经治疗体重减轻的自发缓解被归类为非甲状腺功能亢进。给予碘塞罗宁后,T4的平均±标准差血清浓度(27.9±10.3至11.7±6.4纳摩尔/升)及fT4浓度估算值(21.7±5.4至10.4±4.4皮摩尔/升)显著降低(P<0.001)。判别分析用于从碘甲状腺原氨酸检测中识别变量(例如,T4的绝对浓度或fT4浓度的绝对估算值,或T4或fT4浓度的变化),这些变量可提供最佳的诊断敏感性和特异性。(摘要截短于250字)